aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
MemorialCare Innovation Fund (MCIF) is a private investment firm associated with the MemorialCare Health System, focusing on early to mid-stage companies in the healthcare sector. MCIF targets investments in medical devices, healthcare information technology, and healthcare services, aiming to foster synergistic relationships with MemorialCare's medical centers and affiliated physicians. The firm typically participates in Series A, B, and D rounds.
Notable portfolio companies include AristaMD, Asimily, Avia, Babyscripts, Censinet, Foldax, Laudio, PerfectServe, Prescient Surgical, Protenus, TytoCare, and Xealth. MCIF's investment philosophy emphasizes strategic collaboration and value creation within the healthcare ecosystem. By leveraging MemorialCare's extensive network and resources, MCIF offers unique value-add services to its portfolio companies, enhancing their growth and integration into the healthcare industry.
Also Known As
Memorialcare Innovation Fund, L.P.
Operating Status
Active
Memorialcare Innovation Fund Address
Boston,
Massachusetts
02116
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts